Walnut‐derived peptides combined with intermittent fasting alleviated obesity by modulating gut microbiota and liver metabolome in high‐fat‐diet‐induced obesity mice
Journal of the Science of Food and Agriculture · 2025
DOI: 10.1002/jsfa.14360 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Science of Food and Agriculture, 2025. Verfasst von Jing Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Sport Health Technology College, Jilin Sport University, Changchun, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Obesity, Liver, Juglans. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: jilin academy of educational sciences.
Abstract (Originalsprache)
BACKGROUND This study aimed to investigate the anti‐obesity mechanism of walnut‐derived peptides (WMP) combined with intermittent fasting (IF) through modulating the gut microbiota–liver metabolism axis in high‐fat‐diet (HFD)‐induced obese mice, providing theoretical support for dietary intervention strategies. METHODS Fifty C57BL/6 mice were divided into five groups ( n = 10): normal diet, HFD, WMP, IF and WMP + IF, with an 8‐week intervention. Biochemical analysis, 16S rRNA sequencing, and untargeted liver metabolomics were employed to explore the underlying mechanisms. RESULTS WMP + IF significantly alleviated hyperlipidemia, glucose metabolism disorders, insulin resistance, and visceral fat deposition in HFD mice, while suppressing systemic inflammation. Gut microbiota analysis revealed reduced abundance of Firmicutes , Kineothrix , and Dubosiella , along with a decreased Firmicutes / Bacteroidota (F/B) ratio, whereas Bacteroidota and CAG‐873 were enriched. Correlation analysis demonstrated positive associations between Firmicutes and obesity‐related markers (lipid profiles, liver dysfunction, pro‐inflammatory cytokines), while Bacteroidota exhibited negative correlations. Untargeted metabolomics identified upregulated levels of 16‐hydroxypalmitic acid and 13‐S‐hydroxyoctadecadienoic acid (13(S)‐HODE), alongside activation of ABC transporters and galactose metabolism pathways. Notably, 13(S)‐HODE showed negative correlations with Firmicutes , F/B ratio, and Kineothrix , but positive correlations with Bacteroidota and CAG‐873 . CONCLUSION The synergistic anti‐obesity effects of WMP and IF are mediated through restoring gut microbial balance and reprogramming hepatic metabolic pathways. These findings highlight novel mechanisms involving the gut–liver axis, offering innovative strategies for obesity prevention through natural bioactive compounds combined with dietary interventions. © 2025 Society of Chemical Industry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sport Health Technology College, Jilin Sport University, Changchun, China.
- College of Food Science, Jiangnan University, Wuxi, China.
- College of Food Science and Engineering, Jilin Agricultural University, Changchun, China.
Förderung
- jilin academy of educational sciences
Zitieren
APA
Li, J., Hou, P., Sun, L., Yin, S., Deng, Z., Qi, Y., & Wang, J. (2025). Walnut‐derived peptides combined with intermittent fasting alleviated obesity by modulating gut microbiota and liver metabolome in high‐fat‐diet‐induced obesity mice. Journal of the Science of Food and Agriculture. https://doi.org/10.1002/jsfa.14360
Vancouver
Li J, Hou P, Sun L, Yin S, Deng Z, Qi Y, et al. Walnut‐derived peptides combined with intermittent fasting alleviated obesity by modulating gut microbiota and liver metabolome in high‐fat‐diet‐induced obesity mice. Journal of the Science of Food and Agriculture. 2025. doi:10.1002/jsfa.14360
BibTeX
@article{Li2025,
author = {Li, Jing and Hou, Pan and Sun, Lili and Yin, Shihua and Deng, Zhongzi and Qi, Yuan and Wang, Ji},
title = {Walnut‐derived peptides combined with intermittent fasting alleviated obesity by modulating gut microbiota and liver metabolome in high‐fat‐diet‐induced obesity mice},
journal = {Journal of the Science of Food and Agriculture},
year = {2025},
doi = {10.1002/jsfa.14360}
}
EUVIMED